C23H25NO6
411.4 g/mol
Pharmaceutical IntermediateWarning
4-tert-Butyl hydrogen N-((9H-fluoren-9-ylmethoxy)carbonyl)-L-aspartate
CAS71989-14-5EC276-251-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate
This compound is a protected amino acid derivative used primarily as a building block in peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group and tert-butyl ester moieties, which allow selective deprotection during solid-phase peptide assembly.
Fmoc-based solid-phase peptide synthesis (SPPS)Research reagent for peptide chain elongation
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 71989-14-5
Related Compounds
SimilarStructure SimilarSimilarity 0.73
Fmoc-O-tert-Butyl-L-serine
CAS71989-33-8
pharmaceutical intermediate
ReferenceSame Category
N-Fmoc-L-Asparagine
CAS71989-16-7
pharmaceutical intermediate
ReferenceSame Category
Fmoc-L-glutamic acid 5-tert-butyl ester
CAS71989-18-9
pharmaceutical intermediate
ReferenceSame Category
N-Fmoc-N'-Boc-L-Lysine
CAS71989-26-9
pharmaceutical intermediate
ReferenceSame Category
Fmoc-L-Methionine
CAS71989-28-1
pharmaceutical intermediate
Referencestereoisomer of
Fmoc-D-Aspartic acid beta-tert-butyl ester
CAS112883-39-3
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
Identifiers
IUPAC Name
2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
InChIKey
FODJWPHPWBKDON-UHFFFAOYSA-N
SMILES
CC(C)(C)OC(=O)CC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
Synonyms (9)
- Fmoc-DL-Asp(Otbu)-OH